1. Home
  2. ABEO vs BCML Comparison

ABEO vs BCML Comparison

Compare ABEO & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • BCML
  • Stock Information
  • Founded
  • ABEO N/A
  • BCML 2004
  • Country
  • ABEO United States
  • BCML United States
  • Employees
  • ABEO N/A
  • BCML N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • BCML Major Banks
  • Sector
  • ABEO Health Care
  • BCML Finance
  • Exchange
  • ABEO Nasdaq
  • BCML Nasdaq
  • Market Cap
  • ABEO 277.6M
  • BCML 261.8M
  • IPO Year
  • ABEO 1980
  • BCML N/A
  • Fundamental
  • Price
  • ABEO $6.23
  • BCML $23.91
  • Analyst Decision
  • ABEO Strong Buy
  • BCML
  • Analyst Count
  • ABEO 3
  • BCML 0
  • Target Price
  • ABEO $18.00
  • BCML N/A
  • AVG Volume (30 Days)
  • ABEO 289.4K
  • BCML 17.7K
  • Earning Date
  • ABEO 11-11-2024
  • BCML 10-25-2024
  • Dividend Yield
  • ABEO N/A
  • BCML 1.66%
  • EPS Growth
  • ABEO N/A
  • BCML N/A
  • EPS
  • ABEO N/A
  • BCML 2.12
  • Revenue
  • ABEO N/A
  • BCML $97,490,000.00
  • Revenue This Year
  • ABEO N/A
  • BCML N/A
  • Revenue Next Year
  • ABEO $7,097.06
  • BCML $3.40
  • P/E Ratio
  • ABEO N/A
  • BCML $11.34
  • Revenue Growth
  • ABEO 147.52
  • BCML N/A
  • 52 Week Low
  • ABEO $3.05
  • BCML $18.54
  • 52 Week High
  • ABEO $9.01
  • BCML $25.04
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 55.30
  • BCML 57.95
  • Support Level
  • ABEO $6.39
  • BCML $23.25
  • Resistance Level
  • ABEO $6.74
  • BCML $24.40
  • Average True Range (ATR)
  • ABEO 0.29
  • BCML 0.35
  • MACD
  • ABEO -0.03
  • BCML 0.01
  • Stochastic Oscillator
  • ABEO 48.99
  • BCML 62.60

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

Share on Social Networks: